½ÃÀ庸°í¼­
»óǰÄÚµå
1401420

¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°, Àü´Þ ¸ðµåº°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Peripheral Vascular Stents Market Size Study & Forecast, by Type, by Mode of Delivery, by Product, by End-use, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀåÀº 2022³â ¾à 16¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 7.4% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ®´Â ½ÉÀåÀ̳ª ³ú ¿ÜºÎ¿¡ À§Ä¡ÇÑ ¸»Ãʵ¿¸ÆÀÇ Á¼¾ÆÁö°Å³ª ¸·Èù Ç÷°üÀ» Ä¡·áÇϱâ À§ÇØ °í¾ÈµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ µ¿¸ÆÀº ´Ù¸®, ÆÈ, °ñ¹Ý°ú °°Àº »çÁö¿¡ Ç÷¾×À» °ø±ÞÇÕ´Ï´Ù. ¸»Ãʵ¿¸ÆÁúȯ(PAD)Àº ´Ù¸®, ÆÈ ¹× ±âŸ ºÎÀ§¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀÌ Á¼¾ÆÁö´Â ÁúȯÀ¸·Î, PAD ¹ßº´·ü Áõ°¡, ÀÇ·á Àü¹®°¡¿Í ´ëÁßÀÇ PAD¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡´Â ¼¼°èÀûÀ¸·Î ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ´Â °¡Àå Áß¿äÇÑ ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù. °¡Àå µÎµå·¯Áø ¿äÀÎÀÔ´Ï´Ù.

¶ÇÇÑ, ³ëÀÎ Àα¸ Áõ°¡´Â ÃßÁ¤ ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸ´Â PAD¸¦ Æ÷ÇÔÇÑ Ç÷°ü Áúȯ¿¡ °É¸®±â ½±´Ù. À¯¿£¿¡ µû¸£¸é 2019³â ¼¼°è 65¼¼ ÀÌ»ó Àα¸´Â 7¾ï3õ¸¸ ¸íÀÔ´Ï´Ù. 2050³â¿¡´Â ³ëÀÎ Àα¸°¡ 15¾ï ¸íÀ¸·Î µÎ ¹è·Î ´Ã¾î³¯ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ¿¡ µû¶ó ³ëÀÎ Àα¸ Áõ°¡¿Í ÇÔ²² ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ®¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÏ¿© ¼¼°èÀûÀ¸·Î ½ÃÀå È®´ë°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ºÅÙÆ® ±â¼ú ¹ßÀü¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶ó ±¸Ãà¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ³ôÀº ½Ã¼ú ºñ¿ë°ú ´Ù¸¥ Ä¡·á ¿É¼ÇÀÇ °¡¿ë¼ºÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì´Â °í±Þ ÀÇ·á ½Ã¼³À» Æ÷ÇÔÇÑ Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ®´Â CVD Áø´Ü ¹× Ä¡·á¿¡ µµ¿òÀÌ µÇ´Â °í±Þ ÀÇ·á ÀÎÇÁ¶ó ´öºÐ¿¡ ÀÌ Áö¿ªÀÇ È¯ÀÚµéÀÌ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 10¿ù¿¡ ¹ßÇ¥µÈ ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 40ÃÊ¿¡ ÇÑ ¹ø¾¿ ½ÉÀ帶ºñ°¡ ¹ß»ýÇϸç, ¸Å³â 80¸¸ 5,000¸íÀÇ ¹Ì±¹ÀÎÀÌ ½ÉÀ帶ºñ·Î °íÅë¹Þ°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÂ½Ä »ýȰ ½À°ü, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü, °í·ÉÈ­ µîÀÇ ¿äÀÎÀÌ ¸ðµÎ PAD¿Í °°Àº Áúº´ÀÇ À¯º´·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ®¿Í °°Àº È¿À²ÀûÀÎ ´ëü Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Áö¸®Àû È®Àå Áõ°¡¿Í ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº Áö¿ª Àüü ½ÃÀå ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¸î ³âµ¿¾ÈÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ¹ßÀü
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå ¿ªÇÐ

  • ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ¾à¹° ¿ëÃâ ½ºÅÙÆ®(DES)
    • º£¾î¸ÞÅ» ½ºÅÙÆ®(BMS)
    • »ýüÈí¼ö¼º ½ºÅÙÆ®

Á¦6Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : µô¸®¹ö¸® ¸ðµåº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : µô¸®¹ö¸® ¸ðµåº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : µô¸®¹ö¸® ¸ðµåº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÀÚ±â È®ÀåÇü ½ºÅÙÆ®
    • dz¼± È®ÀåÇü ½ºÅÙÆ®

Á¦7Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : Á¦Ç°º°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Àå°ñ µ¿¸Æ ½ºÅÙÆ®
    • ´ëÅ𠵿¸Æ ½ºÅÙÆ®
    • °æµ¿¸Æ ½ºÅÙÆ®
    • ½ÅÀå µ¿¸Æ ½ºÅÙÆ®
    • ±âŸ ¸»ÃÊ ½ºÅÙÆ®

Á¦8Àå ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø/½ÉÀå¼¾ÅÍ/¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ¸»ÃÊÇ÷°ü¿ë ½ºÅÙÆ® ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Boston Scientific Corporation
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Medtronic
    • Terumo Medical Corporation
    • Abbott
    • Biotronik
    • Lifetech Corporation
    • iVascular SLU
    • Stryker Corporation
    • Cook Medical
    • Microport Scientific Corporation

Á¦11Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 24.01.08

Global Peripheral Vascular Stents Market is valued at approximately USD 1.67 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2023-2030. A peripheral vascular stent is a medical device designed to treat narrowed or blocked blood vessels in the peripheral arteries, which are located outside the heart and brain. These arteries supply blood to the limbs, including the legs, arms, and pelvis. It is used to treat Peripheral Artery Disease (PAD)a condition that results in narrowing of the arteries that supply blood to the legs, arms, and other parts of the body. The rise in incidences of PAD, increasing awareness of PAD among healthcare professionals and the population, and the rising number of government initiatives are the most prominent factors that are fueling the market demand across the globe.

Additionally, the growing geriatric population is exhibiting a positive influence on market growth during the estimated period. The aging population is more prone to develop vascular diseases, including PAD. As per the United Nations, there were 703 million people aged 65 years or over in the world in 2019. The number of older people is projected to double to 1.5 billion in 2050. As a result, with the increasing elderly population, the demand for peripheral vascular stents also rises, which is accelerating the market expansion worldwide. Moreover, growing investment in the advancements in stent technology, as well as the increasing focus on the development of healthcare infrastructure presents various lucrative opportunities over the forecast years. However, the high cost of procedures and the availability of other treatment options are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Peripheral Vascular Stents Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of a well-established healthcare infrastructure that includes advanced healthcare facilities. Peripheral vascular stents are easily accessible to patients in the region because of this advanced medical infrastructure, which aids in the diagnosis and treatment of CVDs. For instance, according to the Centers for Disease Control and Prevention latest report released in October 2022, a heart attack arises in the United States every 40 seconds, and every year, 805,000 Americans are estimated to have a heart attack. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Factors such as sedentary lifestyles, unhealthful eating patterns, and an aging population, all contribute to the rising prevalence of illnesses such as PAD. Accordingly, the need for efficient therapeutic alternatives such as peripheral vascular stents is increasing. Moreover, the increasing geographical expansion of the key market players and technological advancements in the field of peripheral vascular stents are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Boston Scientific Corporation
  • Medtronic
  • Terumo Medical Corporation
  • Abbott
  • Biotronik
  • Lifetech Corporation
  • iVascular SLU
  • Stryker Corporation
  • Cook Medical
  • Microport Scientific Corporation

Recent Developments in the Market:

  • In October 2022, Cordis declared that the company plan to acquire MedAlliance, a Swiss company renowned for its avant-garde drug-eluting balloons. The company aims to increase its worldwide footprint and provide possible therapy to almost two million patients by 2027 by using MedAlliance's innovative SELUTION SLR (Sustained Limus Release) drug-eluting balloon.

Global Peripheral Vascular Stents Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Mode of Delivery, Product, End-use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Drug Eluting Stents (DES)
  • Bare Metal Stents (BMS)
  • Bioabsorbable Stents

By Mode of Delivery:

  • Self-expanding Stents
  • Balloon-expandable Stents

By Product:

  • Iliac Artery Stents
  • Femoral Artery Stents
  • Carotid Artery Stents
  • Renal Artery Stents
  • Other Peripheral Stents

By End-use:

  • Hospital & Cardiac Centers & Ambulatory Surgical Centers
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Peripheral Vascular Stents Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Peripheral Vascular Stents Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Peripheral Vascular Stents Market, by Mode of Delivery, 2020-2030 (USD Billion)
    • 1.2.4. Peripheral Vascular Stents Market, by Product, 2020-2030 (USD Billion)
    • 1.2.5. Peripheral Vascular Stents Market, by End-use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Peripheral Vascular Stents Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Peripheral Vascular Stents Market Dynamics

  • 3.1. Peripheral Vascular Stents Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rapidly growing geriatric population
      • 3.1.1.2. Rising incidences of Peripheral Artery Disease (PAD)
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of procedures
      • 3.1.2.2. Availability of other treatment options
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing investment in the advancements in stent technology
      • 3.1.3.2. Increasing focus on the development of healthcare infrastructure

Chapter 4. Global Peripheral Vascular Stents Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Peripheral Vascular Stents Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Peripheral Vascular Stents Market by Type, Performance - Potential Analysis
  • 5.3. Global Peripheral Vascular Stents Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Peripheral Vascular Stents Market, Sub Segment Analysis
    • 5.4.1. Drug Eluting Stents (DES)
    • 5.4.2. Bare Metal Stents (BMS)
    • 5.4.3. Bioabsorbable Stents

Chapter 6. Global Peripheral Vascular Stents Market, by Mode of Delivery

  • 6.1. Market Snapshot
  • 6.2. Global Peripheral Vascular Stents Market by Mode of Delivery, Performance - Potential Analysis
  • 6.3. Global Peripheral Vascular Stents Market Estimates & Forecasts by Mode of Delivery 2020-2030 (USD Billion)
  • 6.4. Peripheral Vascular Stents Market, Sub Segment Analysis
    • 6.4.1. Self-expanding Stents
    • 6.4.2. Balloon-expandable Stents

Chapter 7. Global Peripheral Vascular Stents Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Peripheral Vascular Stents Market by Product, Performance - Potential Analysis
  • 7.3. Global Peripheral Vascular Stents Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 7.4. Peripheral Vascular Stents Market, Sub Segment Analysis
    • 7.4.1. Iliac Artery Stents
    • 7.4.2. Femoral Artery Stents
    • 7.4.3. Carotid Artery Stents
    • 7.4.4. Renal Artery Stents
    • 7.4.5. Other Peripheral Stents

Chapter 8. Peripheral Vascular Stents Market, by End-use

  • 8.1. Market Snapshot
  • 8.2. Global Peripheral Vascular Stents Market by End-use, Performance - Potential Analysis
  • 8.3. Global Peripheral Vascular Stents Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
  • 8.4. Peripheral Vascular Stents Market, Sub Segment Analysis
    • 8.4.1. Hospital & Cardiac Centers & Ambulatory Surgical Centers
    • 8.4.2. Ambulatory Surgical Centers
    • 8.4.3. Others

Chapter 9. Global Peripheral Vascular Stents Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Peripheral Vascular Stents Market, Regional Market Snapshot
  • 9.4. North America Peripheral Vascular Stents Market
    • 9.4.1. U.S. Peripheral Vascular Stents Market
      • 9.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Mode of Delivery breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Product breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Peripheral Vascular Stents Market
  • 9.5. Europe Peripheral Vascular Stents Market Snapshot
    • 9.5.1. U.K. Peripheral Vascular Stents Market
    • 9.5.2. Germany Peripheral Vascular Stents Market
    • 9.5.3. France Peripheral Vascular Stents Market
    • 9.5.4. Spain Peripheral Vascular Stents Market
    • 9.5.5. Italy Peripheral Vascular Stents Market
    • 9.5.6. Rest of Europe Peripheral Vascular Stents Market
  • 9.6. Asia-Pacific Peripheral Vascular Stents Market Snapshot
    • 9.6.1. China Peripheral Vascular Stents Market
    • 9.6.2. India Peripheral Vascular Stents Market
    • 9.6.3. Japan Peripheral Vascular Stents Market
    • 9.6.4. Australia Peripheral Vascular Stents Market
    • 9.6.5. South Korea Peripheral Vascular Stents Market
    • 9.6.6. Rest of Asia Pacific Peripheral Vascular Stents Market
  • 9.7. Latin America Peripheral Vascular Stents Market Snapshot
    • 9.7.1. Brazil Peripheral Vascular Stents Market
    • 9.7.2. Mexico Peripheral Vascular Stents Market
  • 9.8. Middle East & Africa Peripheral Vascular Stents Market
    • 9.8.1. Saudi Arabia Peripheral Vascular Stents Market
    • 9.8.2. South Africa Peripheral Vascular Stents Market
    • 9.8.3. Rest of Middle East & Africa Peripheral Vascular Stents Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Boston Scientific Corporation
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Medtronic
    • 10.3.3. Terumo Medical Corporation
    • 10.3.4. Abbott
    • 10.3.5. Biotronik
    • 10.3.6. Lifetech Corporation
    • 10.3.7. iVascular SLU
    • 10.3.8. Stryker Corporation
    • 10.3.9. Cook Medical
    • 10.3.10. Microport Scientific Corporation

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦